CRIP2 and skin squamous cell carcinoma: Herein, CRIP2 was identified to be a direct interacting partner of HOXA9 and acted as a tumor suppressor in cSCC, consistent with the previous-reported anti-carcinogenic role of CRIP244,45,57.